Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

134.01 -0.40 (-0.30%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 295,772
Open 133.78
Bid (Size) 120.03 (1)
Ask (Size) 133.72 (1)
Prev. Close 134.41
Today's Range 132.17 - 135.68
52wk Range 75.22 - 190.82
Shares Outstanding 52,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 
Via InvestorPlace
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
From Masimo
Via Business Wire

Performance

YTD
+16.93%
+16.93%
1 Month
-7.47%
-7.47%
3 Month
+3.92%
+3.92%
6 Month
+65.18%
+65.18%
1 Year
-29.12%
-29.12%

More News

Read More
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
From Masimo
Via Business Wire
Forecasting The Future: 6 Analyst Projections For Masimo
Via Benzinga
Analyst Scoreboard: 5 Ratings For Masimo
Via Benzinga
Masimo Corp. (NASDAQ: MASI) Making Surprising Moves in Monday Session
Via Investor Brand Network
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
How's AT&T Handling Things?
Via The Motley Fool
Can a New CEO Fix Boeing?
Via The Motley Fool
Boeing's Leadership Shake-Up
Via The Motley Fool
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
From Masimo
Via Business Wire
Masimo Breaks Out To Eight-Month High On Proposed Consumer Biz Separation
Via Investor's Business Daily
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence
Via Benzinga
Wall Street Set To Open Weak Lower As Tech Feels China Chill: Analyst Says Stay Bullish 'If And Until This Changes'
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Politan Nominates Two Independent Candidates for Masimo Board
From Politan Capital Management
Via Business Wire
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
From Masimo Corporation
Via Business Wire
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Masimo Named One of Fast Company’s Most Innovative Companies in North America
From Masimo
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.